Cargando…

A Novel Artificial Neural Network Prognostic Model Based on a Cancer-Associated Fibroblast Activation Score System in Hepatocellular Carcinoma

INTRODUCTION: Hepatocellular carcinoma (HCC) ranks fourth as the most common cause of cancer-related death. It is vital to identify the mechanism of progression and predict the prognosis for patients with HCC. Previous studies have found that cancer-associated fibroblasts (CAFs) promote tumor prolif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yiqiao, Tan, Huaicheng, Yu, Ting, Tian, Jiangfang, Shi, Huashan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304772/ https://www.ncbi.nlm.nih.gov/pubmed/35874676 http://dx.doi.org/10.3389/fimmu.2022.927041

Ejemplares similares

Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
por: Wang, Yang, et al.
Publicado: (2021)

Integratively Genomic Analysis Reveals the Prognostic and Immunological Characteristics of Pyroptosis and Ferroptosis in Pancreatic Cancer for Precision Immunotherapy
por: Yu, Ting, et al.
Publicado: (2022)

Assessing the efficacy of immunotherapy in lung squamous carcinoma using artificial intelligence neural network
por: Li, Siqi, et al.
Publicado: (2022)

Development and Validation of TACE Refractoriness-Related Diagnostic and Prognostic Scores and Characterization of Tumor Microenvironment Infiltration in Hepatocellular Carcinoma
por: He, Qifan, et al.
Publicado: (2022)

New Artificial Intelligence Score and Immune Infiltrates as Prognostic Factors in Colorectal Cancer With Brain Metastases
por: Randrian, Violaine, et al.
Publicado: (2021)

Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2023)

Immunopeptidomic Data Integration to Artificial Neural Networks Enhances Protein-Drug Immunogenicity Prediction
por: Barra, Carolina, et al.
Publicado: (2020)

A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration
por: Long, Meiying, et al.
Publicado: (2022)

Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
por: Xiang, Shixin, et al.
Publicado: (2021)

Development and Verification of a Combined Immune- and Metabolism-Related Prognostic Signature for Hepatocellular Carcinoma
por: Guo, Yuanyuan, et al.
Publicado: (2022)

Model-interpreted outcomes of artificial neural networks classifying immune biomarkers associated with severe infections in ICU
por: Martinez, Gustavo Sganzerla, et al.
Publicado: (2023)

The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins
por: Wang, Yang, et al.
Publicado: (2021)

Identification pyroptosis-related gene signature to predict prognosis and associated regulation axis in colon cancer
por: Zhou, Kexun, et al.
Publicado: (2022)

Identifying tumor antigens and immuno‐subtyping in colon adenocarcinoma to facilitate the development of mRNA vaccine
por: Tan, Huaicheng, et al.
Publicado: (2022)

Identification of subclusters and prognostic genes based on glycolysis/gluconeogenesis in hepatocellular carcinoma
por: Chen, Dan, et al.
Publicado: (2023)

Immunogenic landscape and risk score prediction based on unfolded protein response (UPR)-related molecular subtypes in hepatocellular carcinoma
por: Guo, Hanyao, et al.
Publicado: (2023)

Cuproptosis-Related Risk Score Predicts Prognosis and Characterizes the Tumor Microenvironment in Hepatocellular Carcinoma
por: Zhang, Zhen, et al.
Publicado: (2022)

Artificial Neural Network Analysis-Based Immune-Related Signatures of Primary Non-Response to Infliximab in Patients With Ulcerative Colitis
por: Chen, Xuanfu, et al.
Publicado: (2021)

Crosstalk between fibroblasts and T cells in immune networks
por: Lee, Byunghyuk, et al.
Publicado: (2023)

EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Shu, Yang, et al.
Publicado: (2022)

Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma
por: Wen, Fukai, et al.
Publicado: (2023)

Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma
por: Ding, Lin, et al.
Publicado: (2022)

A novel diagnostic four-gene signature for hepatocellular carcinoma based on artificial neural network: Development, validation, and drug screening
por: Chen, Min, et al.
Publicado: (2022)

A Knowledge-Based Discovery Approach Couples Artificial Neural Networks With Weight Engineering to Uncover Immune-Related Processes Underpinning Clinical Traits of Breast Cancer
por: Zhang, Cheng, et al.
Publicado: (2022)

Aging-related features predict prognosis and immunotherapy efficacy in hepatocellular carcinoma
por: Hong, Ting, et al.
Publicado: (2022)

Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data
por: Yu, Lianghe, et al.
Publicado: (2022)

Artificial Neural Network as a Classifier for the Identification of Hepatocellular Carcinoma Through Prognosticgene Signatures
por: Jujjavarapu, Satya Eswari, et al.
Publicado: (2018)

Scoring System for Tumor-Infiltrating Lymphocytes and Its Prognostic Value for Gastric Cancer
por: Zhang, Dachuan, et al.
Publicado: (2019)

The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Xue, Jun-Shuai, et al.
Publicado: (2022)

Identification of cuproptosis-related subtypes, cuproptosis-related gene prognostic index in hepatocellular carcinoma
por: Ding, Lei, et al.
Publicado: (2022)

CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma
por: Liu, Yanli, et al.
Publicado: (2022)

Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma
por: Lu, Juan, et al.
Publicado: (2022)

Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma
por: Liu, Zhaochen, et al.
Publicado: (2022)

Identification and validation of a prognostic-related mutant gene DNAH5 for hepatocellular carcinoma
por: Song, Zebing, et al.
Publicado: (2023)

Prognostic stratification based on m(5)C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma
por: Liu, Ping, et al.
Publicado: (2022)

Natural product scores and fingerprints extracted from artificial neural networks
por: Menke, Janosch, et al.
Publicado: (2021)

Prognostic scores for hepatocellular carcinoma: none is the winner
por: Cammà, Calogero, et al.
Publicado: (2009)

Prognostic model of immune checkpoint inhibitors combined with anti-angiogenic agents in unresectable hepatocellular carcinoma
por: Li, Xiaomi, et al.
Publicado: (2022)

Prognostic value of the immunohistochemical score based on four markers in head and neck squamous cell carcinoma
por: Xu, Qing-Qing, et al.
Publicado: (2023)

Mortality Predicted Accuracy for Hepatocellular Carcinoma Patients with Hepatic Resection Using Artificial Neural Network
por: Chiu, Herng-Chia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3q8hempidsp1tp19ps8bhdtsdc